{"id":51028,"date":"2023-02-03T20:23:03","date_gmt":"2023-02-03T20:23:03","guid":{"rendered":"http:\/\/www.brandon.ddtest.info\/multisite-test\/abbvies-humira-gets-a-u-s-rival-but-costs-could-stay-high-reuters\/"},"modified":"2023-02-03T20:23:03","modified_gmt":"2023-02-03T20:23:03","slug":"abbvies-humira-gets-a-u-s-rival-but-costs-could-stay-high-reuters","status":"publish","type":"post","link":"http:\/\/www.brandon.ddtest.info\/multisite-test\/abbvies-humira-gets-a-u-s-rival-but-costs-could-stay-high-reuters\/","title":{"rendered":"AbbVie's Humira gets a U.S. rival, but costs could stay high – Reuters"},"content":{"rendered":"

\n<\/p>\n

    \n
  1. AbbVie’s Humira gets a U.S. rival, but costs could stay high<\/a>  Reuters<\/font><\/li>\n
  2. The End of Humira’s Monopoly<\/a>  The Dispatch<\/font><\/li>\n
  3. Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar<\/a>  Yahoo! Voices<\/font><\/li>\n
  4. Amgen’s Amjevita ready to chip at Humira’s crown<\/a>  FiercePharma<\/font><\/li>\n
  5. AbbVie Stock: The 20-Year Humira Monopoly Ends; So, What’s Next? | Investor’s Business Daily<\/a>  Investor’s Business Daily<\/font><\/li>\n
  6. View Full Coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n\n
    Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    AbbVie’s Humira gets a U.S. rival, but costs could stay high  Reuters The End of Humira’s Monopoly  The Dispatch Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar  Yahoo! Voices Amgen’s Amjevita ready to chip at Humira’s crown  FiercePharma AbbVie Stock: The 20-Year Humira Monopoly Ends; So, What’s Next? | Investor’s Business Daily  Investor’s Business Daily View Full …<\/p>\n","protected":false},"author":1,"featured_media":51029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[161],"tags":[],"_links":{"self":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/51028"}],"collection":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/comments?post=51028"}],"version-history":[{"count":0,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/51028\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media\/51029"}],"wp:attachment":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media?parent=51028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/categories?post=51028"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/tags?post=51028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}